Amplification and overexpression of E2F3 in human bladder cancer

Oncogene

Volumn 23, Issue 8, 2004, Pages 1627-1630

  Feber, Andrew ^a   Clark, Jeremy ^a   Goodwin, Graham ^a   Dodson, Andrew R ^b   Smith, Paul H ^b   Fletcher, Anne ^a   Edwards, Sandra ^a   Flohr, Penny ^a   Falconer, Alison ^c   Roe, Toby ^a   Kovacs, Gyula ^d   Dennis, Nening ^a   Fisher, Cyril ^c   Wooster, Richard ^e   Huddart, Robert ^c   Foster, Christopher S ^b   Cooper, Colin S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

6p22 amplicon; Bladder cancer; E2F3 gene

Indexed keywords

MESSENGER RNA; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR E2F3; DNA; E2F3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CELL CYCLE; CHROMOSOME 6P; CONTROLLED STUDY; GENE ACTIVATION; GENE AMPLIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ONCOGENE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; BLADDER TUMOR; CELL NUCLEUS; CHROMOSOME 6; CHROMOSOME MAP; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CELL NUCLEUS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; DNA, NEOPLASM; E2F3 TRANSCRIPTION FACTOR; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TRANSCRIPTION FACTORS; URINARY BLADDER NEOPLASMS;

EID: 1542426648     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207274     Document Type: Article

References (29)

1. Bruch J, Schulz WA, Haussler J, Melzner I, Bruderlein S, Moller P, Kemmerling R, Vogel W and Hameister H. (2000). Cancer Res., 60, 4526-4530.
2. Cappellen D, De Oliveira C, Ricol D, de Medina S, Bourdin J, Sastre-Garau X, Chopin D, Thiery JP and Radvanyi F. (1999). Nat. Genet., 1, 18-20.
3. Clark J, Edwards S, John M, Flohr P, Gordon T, Maillard K, Giddings I, Brown C, Bagherzadeh A, Campbell C, Shipley J, Wooster R and Cooper CS. (2002). Genes Chromosomes Cancer, 34, 104-114.
4. Clark J, Lu YJ, Sidhar SK, Parker C, Gill S, Smedley D, Hamoudi R, Linehan WM, Shipley J and Cooper CS. (1997). Oncogene, 15, 2233-2239.
5. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y and Foster CS. (2000). Cancer Res., 60, 7099-7105.
6. Florl AR and Schulz WA. (2003). Gene Chromosomes Cancer, 37, 41-148.
7. Giangrande PH, Hallstrom TC, Tunyaplin C, Calame K and Nevins JR. (2003). Mol. Cell. Biol., 11, 3707-3720.
8. Hovey RM, Chu L, Balazs M, DeVries S, Moore D, Sauter G, Carroll PR and Waldman FM. (1998). Cancer Res., 58, 3555-3560.
9. Huang E, Ishida S, Pittman J, Dressman H, Bild A, Kloos M, D'Amico M, Pestell RG, West M and Nevins JR. (2003). Nat. Genet., 34, 226-230.
10. Humbert PO, Verona R, Trimarchi JM, Rogers C, Dandapani S and Lees JA. (2000). Genes Dev., 14, 690-703.
11. Knowles MA. (2001). Mol. Pathol., 54, 215-221.
12. Koo SH, Kwon KC, Ihm CH, Jeon YM, Park JW and Sul CK. (1999). Cancer Genet. Cytogenet., 110, 87-93.
13. Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS and Nevins JR. (1998). Genes Dev., 12, 2120-2130.
14. Markl ID and Jones PA. (1998). Cancer Res., 58, 5348-5353.
15. Martelli F, Hamilton T, Silver DP, Sharpless NE, Bardeesy N, Rokas M, DePinho RA, Livingston DM and Grossman SR. (2001). Proc. Natl. Acad. Sci. USA, 98, 4455-4460.
16. Ortega S, Malumbres M and Barbacid M. (2002). Biochim. Biophys. Acta, 1602, 73-87.
17. Prat E, Bernues M, Caballin MR, Egozcue J, Gelabert A and Miro R. (2001). Urology, 57, 986-992.
18. Rieger KM, Little AF, Swart JM, Kastrinakis WV, Fitzgerald JM, Hess DT, Libertino JA and Summerhayes IC. (1995). Br. J. Cancer, 72, 683-690.
19. Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knonagel H, Moch H, Mihatsch MJ, Gasser TC and Sauter G. (1999). Cancer Res., 59, 5687-5691.
20. Sambrook J, Fritsch EF and Maniatis T. (1989). Molecular Cloning, A Laboratory Manual. Cold Spring Harbour Laboratory Press: Cold Spring Harbour.
21. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704-707.
22. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J and Cooper CS. (1996). Hum. Mol. Genet., 5, 1333-1338.
23. Simon R, Burger H, Semjonow A, Hertle L, Terpe HJ and Bocker W. (2000). Int. J. Oncol., 17, 1025-1029.
24. Skalsky YM, Ajuh PM, Parker C, Lamond AI, Goodwin G and Cooper CS. (2001). Oncogene, 20, 178-187.
25. Stein JP, Ginsberg DA and Grossfeld GD. (1998). J. Natl. Cancer Inst., 90, 1072-1079.
26. Terracciano L, Richter J, Tornillo L, Beffa L, Diener PA, Maurer R, Gasser TC, Moch H, Mihatsch MJ and Sauter G. (1999). J. Pathol., 189, 230-235.
27. Tomovska S, Richter J, Suess K, Wagner U, Rozenblum E, Gasser TC, Moch H, Mihatsch MJ, Sauter G and Schraml P. (2001). Int. J. Oncol., 18, 1239-1244.
28. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN and Waldman FM. (2003). Cancer Res., 63, 2872-2880.
29. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML and Leone G. (2001). Nature, 414, 457-462.